Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: A single-center experience

Annals of Transplantation

Volumn 19, Issue 1, 2014, Pages 277-282

  Yang, Ji Wei ^a   Wang, Jian Ning ^a   Men, Tong Yi ^a   Zhang, Xiao Ming ^a   Li, Xian Duo ^a   Shen, Bin ^a   Li, Guang Yun ^a   Chen, Dong Dong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Acute rejection; Immunosuppression induction; Rabbit anti human antithymocyte globulin; Renal transplantation

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN A; DAPSONE; DEXAMETHASONE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE; THROMBOCYTOPENIA;

ACUTE DISEASE; ADULT; AGED; ANIMALS; ANTILYMPHOCYTE SERUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDUCTION CHEMOTHERAPY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RABBITS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84902129056     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.890069     Document Type: Review

References (19)

1. Clesca P, Dirlando M, Park SI et al: Thymoglobulin and rate of infectious complications after transplantation. Transplant Proc, 2007; 39(2): 463-64
2. Laftavi MR, Patel S, Soliman MR et al: Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy. Transplant Proc, 2011; 43(2): 466-68
3. Weimert NA, Alloway RR: Renal transplantation in high-risk patients. Drugs, 2007; 67(11): 1603-27
4. Hariharan S, Johnson CP, Bresnahan BA et al: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med, 2000; 342(9): 605-12
5. Nashan B: Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review. BioDrugs, 2005; 19(1): 39-46
6. Ciancio G, Burke GW, Miller J: Induction therapy in renal transplantation: an overview of current developments. Drugs, 2007; 67(18): 2667-80
7. Larson TS, Dean PG, Stegall MD et al: Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant, 2006; 6(3): 514-22
8. Gralla J, Wiseman AC: The impact of IL2ra induction therapy in kidney transplantation using tacrolimus-and mycophenolate-based immunosuppression. Transplantation, 2010; 90(6): 639-44
9. Castro MC, Araujo LM, Nahas WC et al: Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapies. Transplant Proc, 2004; 36(4): 874-76
10. McKeage K, McCormack PL: Basiliximab: a review of its use as induction therapy in renal transplantation. BioDrugs, 2010; 24(1): 55-76
11. Thymoglobulin Prescribing Information, Genzyme, Cambridge, Mass, USA, 2005
12. Shapiro R, Young JB, Milford EL et al: Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant, 2005; 5(4 Pt 2): 874-86
13. Brennan DC, Schnitzler MA: Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med, 2008; 359(16): 1736-38
14. Gaber AO, Monaco AP, Russell JA et al: Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology. Drugs, 2010; 70(6): 691-732
15. Paul LC: Chronic allograft nephropathy-a model of impaired repair from injury? Nephrol Dial Transplant, 2000; 15(2): 149-51
16. Stevens RB, Mercer DF, Grant WJ et al: Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation, 2008; 85(10): 1391-99
17. Laftavi MR, Alnimri M, Weber-Shrikant E et al: Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Transplant Proc, 2011; 43(2): 458-61
18. Brennan DC, Daller JA, Lake KD et al: Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med, 2006; 355(19): 1967-77
19. Cameron JS: Renal transplantation in the elderly. Int Urol Nephrol, 2000; 32(2): 193-201